HRT Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History

HRT Financial’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-552,003	Closed	-$51.3M	–	4195
2021 Q4	$51.3M	Buy	+552,003	New	+$36.4M	0.3%	33
2021 Q2	–	Sell	-5,477	Closed	-$380K	–	3791
2021 Q1	$380K	Buy	+5,477	New	+$421K	﹤0.01%	1973
2020 Q3	–	Sell	-3,748	Closed	-$235K	–	2525
2020 Q2	$235K	Buy	+3,748	New	+$206K	0.01%	1088
2018 Q4	–	Sell	-8,801	Closed	-$405K	–	793
2018 Q3	$405K	Buy	+8,801	New	+$357K	0.06%	199
2015 Q3	–	Sell	-3,197	Closed	-$148K	–	207
2015 Q2	$148K	Buy	+3,197	New	+$139K	0.07%	134

HRT Financial's ARNA Position: Q1 2022 in Review

HRT Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 552,003 shares — an estimated $51.3M sold.

HRT Financial first reported a position in ARNA in Q2 2015 and held it in 5 quarters. The position peaked at $51.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

HRT Financial reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
HRT Financial sold 552,003 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $51.3M.
HRT Financial first reported a position in Arena Pharmaceuticals Inc in Q2 2015 and held it in 5 quarters.
HRT Financial's Arena Pharmaceuticals Inc position peaked at $51.3M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.